Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-7919

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-7919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A chart showing pharmacokinetic (PK) fold changes and 90% confidence interval (CI) recommendations for venlafaxine interacting with various drugs. The chart plots changes in Cmax, AUC, and ODV relative to reference values, with corresponding clinical recommendations such as dose adjustments or cautions for drugs like ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic fold change chart showing the interaction effects of various drugs on the analyte levels (Cmax and AUC) with corresponding 90% confidence intervals. The chart includes interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, along with recommendations for dose adjustments or caution notes for each interaction.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A forest plot chart showing pharmacokinetic (PK) changes in Venlafaxine Hydrochloride across special populations. It compares Cmax, AUC, and ODV parameters relative to a reference value, with dose adjustment recommendations on the right for hepatic impairment, renal impairment, CYP2D6 polymorphism, age, and gender.*

FDA Label Image

Venlafaxine HCl Extended-release Capsules 37.5mg (Venlafaxine Fig4)

Label for Venlafaxine Hydrochloride Extended-Release Capsules 37.5 mg, a human prescription drug by Preferred Pharmaceuticals Inc. The label includes dosing directions in English and Spanish, storage instructions, and manufacturer information from Aurobindo Pharma Limited. The capsules are described as white and gray with imprint "E 73." The label also features a barcode and caution about drug transfer.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride depicted by its molecular diagram showing its key functional groups, including a cyclohexanol ring, methoxyphenyl group, and tertiary amine, consistent with the active ingredient venlafaxine hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.